arrow
J

Jingliao Zhang

Chinese Academy of Medical Sciences and Peking Union Medical College
H指数:16
被引数:1,063

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Publisher Correction: Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy

出版商更正: 从CD34造血干细胞和祖细胞大规模生成墨水和汽车墨水细胞用于过继免疫治疗

2025-11-260
PRE
Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy

从CD34+造血干细胞和祖细胞大规模制备iNK和CAR-iNK细胞用于过继性免疫治疗

2025-10-070
PRE
Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies

源自多能干细胞的工程化CRO-CD7 car-nk细胞可避免自相残杀并有效抑制人类T细胞恶性肿瘤

2025-05-190
OA
Safety and Efficacy of Olverembatinib (HQP1351) Combined with Lisaftoclax (APG-2575) in Children and Adolescents with Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (R/R Ph plus ALL): First Report from a Phase 1 Study

奥勒美巴替尼(HQP1351)联合丽莎福克(APG-2575)在复发/难治性费城染色体阳性急性淋巴细胞白血病(R/R Ph plus ALL)儿童和青少年中的安全性与有效性:一项I期研究的首次报告

BLOOD
IF23.1
2024-11-050
PRE
Minimal residual disease monitoring in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia: prognostic significance and correlation between multiparameter flow cytometry and real-time quantitative polymerase chain reaction
2024-05-021
OAAI
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia
2021-01-2186
OAAI
Acquisition of drug resistance mutations during chemotherapy treatment in pediatric acute lymphoblastic leukemia
2019-07-010
PRE